Condition
HIV-Associated Focal Segmental Glomerulosclerosis
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT00001393Completed
Genetic Markers for Focal Segmental Glomerulosclerosis
NCT00524992CompletedPrimary
Evaluation of Albuminuria HIV-Infected Patients
Showing all 2 trials
Research Network
Active Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Top Investigators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Related Conditions
- Albuminuria1
- Hivassociated Collapsing Glomerulopathy1
- Focal Segmental Glomerulosclerosis1
- Proteinuria1
- Renal Tubular Toxicity1